Transparent Pricing

How Much Does Compounded Semaglutide and Tirzepatide Cost?

At IVUSE+, the price is the price. Compounded semaglutide and tirzepatide are billed at a flat monthly rate with no subscription, no membership fees, and no surprise charges. Here is exactly what you pay and what is included.


IVUSE+ pricing

Compounded Semaglutide
$285/month

Flat-rate. Includes your medication, telehealth consultation, and shipping. No subscription, no membership fee.

Compounded Tirzepatide
$360/month

Flat-rate. Includes your medication, telehealth consultation, and shipping. No subscription, no membership fee.

New patients may be eligible for a limited introductory offer. Pricing is disclosed upfront, before you commit.

What is included

The medication

Your compounded semaglutide or tirzepatide, prepared by a licensed 503A/503B pharmacy.

Telehealth care

Your online evaluation and medical review by a licensed clinician, plus dose adjustments.

Shipping

Discreet delivery to your door, included in the monthly price.

Ongoing support

Access to your clinical team for questions and check-ins throughout your protocol.

Why flat-rate pricing matters

Your price does not change as your dose goes up. Many weight-loss programs raise the monthly cost each time your dose is titrated higher. At IVUSE+, semaglutide is $285 and tirzepatide is $360 regardless of where your dose lands.

No subscription lock-in and no membership fees. You are not paying a separate platform or membership charge on top of the medication, and there is no auto-escalating subscription.

No insurance required. IVUSE+ pricing is a simple cash price. You do not need to file insurance or navigate prior authorizations to get started.

The bigger GLP-1 cost picture

GLP-1 pricing across the category changes often. Branded medications such as Wegovy, Ozempic, and Zepbound carry list prices roughly in the $1,000 to $1,350 per month range without insurance, though the manufacturers now offer lower direct cash-pay options that vary by medication and dose.

Compounded semaglutide and tirzepatide are a separate category: they contain the same FDA-approved active ingredients and are prepared by a licensed compounding pharmacy, but they are not the branded finished products and are not themselves FDA-approved as finished products. What IVUSE+ offers is a single, predictable flat monthly price with everything included, so you always know what you are paying.

Common questions

How much does compounded semaglutide cost at IVUSE+?

Compounded semaglutide is $285 per month, flat-rate, with your medication, telehealth consultation, and shipping included. There is no subscription or membership fee.

How much does compounded tirzepatide cost?

Compounded tirzepatide is $360 per month at IVUSE+, flat-rate, with medication, telehealth consultation, and shipping included.

Does the price change as my dose increases?

No. The monthly price is flat regardless of your dose. Semaglutide stays $285 and tirzepatide stays $360 as your clinician titrates your dose.

Do I need insurance?

No. IVUSE+ pricing is a simple cash price with no insurance filing or prior authorization required.

See what you qualify for

Pricing is only part of the picture. A licensed clinician on the IVUSE+ Clinical Team reviews your health history to determine whether treatment is appropriate. Complete a confidential assessment to get started, available to eligible patients in all 50 states.

See if you qualify

Keep reading

Semaglutide vs. Tirzepatide

Which one is right for you?

Medically reviewed by the IVUSE+ Clinical Team · Last reviewed July 2026

Pricing is current as of the last review date and subject to change. Third-party medication prices referenced are general list-price ranges that vary by pharmacy, insurance, and manufacturer program. Compounded medications are not FDA-approved but contain FDA-approved active ingredients, and are dispensed only pursuant to a valid prescription after a telehealth consultation with a licensed clinician. Individual results vary. IVUSE+ does not guarantee specific weight-loss outcomes.